VistaGen Therapeutics, Inc.
Market price today
VistaGen Therapeutics, Inc. (VTGN) Stock Price & Analysis
Gross Profit Margin
Operating Profit Margin
Net Profit Margin
Return on Assets
Return on Equity
Return on Capital Employed
Company general description and statistics
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product candidature also has potential to treat a range of anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, preprocedural anxiety, and panic disorders. The company's CNS pipeline also comprises PH10, a rapid-onset neuroactive nasal spray, which is in preparation for Phase 2B clinical development as a stand-alone treatment for major depressive disorder (MDD); and AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is in development in combination with oral probenecid as a potential treatment of levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. It has contract research and development agreement with Cato Research Ltd.; license agreement with Pherin Pharmaceuticals, Inc.; and license and collaboration agreement with EverInsight Therapeutics Inc. VistaGen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California.
Return on Investments
Frequently Asked Question
How many company shares are outstanding in 2023?
There are stock number shares outstanding of VistaGen Therapeutics, Inc. (VTGN) on the NASDAQ in 2023.
What is P/E ratio of enterprise in 2023?
The current P/E ratio of enterprise is -0.851 in 2023.
What is the ticker symbol of VistaGen Therapeutics, Inc. stock?
The ticker symbol of VistaGen Therapeutics, Inc. stock is VTGN.
What is company IPO date?
IPO date of VistaGen Therapeutics, Inc. is 2011-06-21.
What is company current share price?
Current share price is 5.360 USD.
What is stock market cap today?
The market cap of stock today is 50182678.000.
What is PEG ratio in 2023?
The current 0.000 is 0.000 in 2023.
What is the number of employees in 2023?
In 2023 the company has 32.